The forecasted data for the re-import of penicillins or streptomycins not in dosage forms to Canada shows a steady increase from 2024 to 2028, starting at 17.85 kilograms in 2024 and reaching 20.07 kilograms in 2028. The figures reflect consistent year-on-year growth, indicating a reliable demand increase. This trend is characterized by an average annual growth rate (CAGR) over these five years.

In 2023, the known data point was 17.28 kilograms, thus marking a year-on-year growth of approximately 3.3% into 2024. Trend observations indicate an ongoing rise in demand, likely driven by pharmaceutical manufacturing needs.

Future trends to watch for include:

Potential impacts of global health trends or pandemics increasing antibiotic demand.
Regulatory changes affecting drug importation and exportation.
Technological advancements could shift drug synthesis methods, impacting material requirements.